Vilobelimab
Product Specifications
CAS Number
2250440-41-4
Target
SARS-CoV, Complement System
Related Pathways
Immunology/Inflammation, Microbiology/Virology
Purity
0.99
Bioactivity
Vilobelimab (CaCP-29) is a human-mouse chimeric IgG antibody targeting human complement component 5a, a C5a inhibitor that inhibits neutrophil activation, and can be used for the study of systemic inflammation caused by SARS-CoV-2 infection.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
